Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Before prescribing this medication, healthcare professionals are encouraged to understand the guidelines the patient must follow
52-WEEK TRIAL: Clinical Trial Identifier: NCT02414958 Trial name: Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes Over 52 Weeks (EASE-2) Diabetes type: Type 1 diabetes What its testing: This trial will assess the efficacy, safety, and tolerability of two doses of Jardiance in people with type 1 diabetes already on a multiple daily injection (MDI) insulin regimen
7 Tng tc Cha c thng tin tng tc
Most often, the insurance provider will offer more thorough coverage for lower tiers, while higher-tier drugs may come with higher costs from copays or coinsurance
US$ 27.90
US$ 26.68
US$ 27.35
US$ 21.57
